Trial Profile
A randomized, pharmacodynamic comparison of ticagrelor 60mg bid vsprasugrel 5mg in patients with prior myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Prasugrel
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- Acronyms ALTIC-2
- 11 Sep 2017 New trial record